High materiality7/10
BeOne Medicines upgraded to Buy from Hold at Jefferies
Why it may matterVerify against the original reporting
Bullish upgrade; price target indicates upside.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
BeOne Medicines (ONC) upgraded from Hold to Buy by Jefferies with a target price of $380; current price is $298.7.
- Jefferies upgrades ONC to Buy; target $380; price $298.7.
Key facts
- 01
Target: $380
- 02
Posted price: $298.7
- 03
Analyst firm: Jefferies
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.